Consultations from NICE seeking views on a clinical practice guideline developments for:

• Familial hypercholesterolaemia: consultation
• Lipid modification: Consultation on section 4.3 – Cardiovascular risk assessment

and requesting views on the use of erlotinib to treat small-cell cancer.

• Lung cancer (non-small cell) – erlotinib (appraisal consultation)